BAR HARBOR — Nadia Rosenthal, a world-renowned researcher and leader in mammalian molecular genetics, will join The Jackson Laboratory (JAX) as scientific director of the institution’s Mammalian Genetics headquarters.
Starting in May, Rosenthal will begin a transition from her current post as founding director of the Australian Regenerative Medicine Institute of Monash University in Melbourne, Australia, to the newly created JAX position.
Rosenthal’s research uses mammalian genetics to explore the embryonic development of heart and skeletal muscle and the regeneration of adult tissues. She focuses on muscle and cardiac developmental genetics and the role of growth factors, stem cells and the immune system in tissue regeneration.
“Her work in the biology of insulin-like growth factors has led to significant advances in novel cell-based therapies for muscle and heart aging and disease,” said JAX President and CEO Edison Liu.
The new appointment is in many ways a homecoming for Rosenthal. From the age of two, she spent summers with her family near Mount Desert Island. After earning her doctorate in biochemistry at Harvard Medical School, she started collaborating with JAX researchers, developing her longstanding focus on mammalian genetics using the mouse as model. As her career progressed, she has continued to connect and collaborate with The Jackson Laboratory, eventually joining their board of scientific counselors in 2011.
The Jackson Laboratory is an independent, nonprofit biomedical research institution and National Cancer Institute-designated Cancer Center based in Bar Harbor, with a facility in Sacramento, Calif., and a new genomic medicine institute in Farmington, Conn. It employs 1,600 staff, and its mission is to discover precise genomic solutions for disease and empower the global biomedical community in the shared quest to improve human health.